Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Non-Small-Cell Lung Cancer | Unmet Need | EGFR-Mutation-Positive Metastatic Nonsquamous NSCLC | US/EU5 | 2023
Approximately 20% of Western patients with nonsquamous NSCLC present with EGFR mutations, creating a market for targeted and personalized treatments. Although the market for EGFR-mutation-positive…
Multiple Myeloma – Current Treatment – Treatment Sequencing – Multiple Myeloma (US)
Key benefits and usesPinpoint current drug positioning and uptake in one snapshot to facilitate forecasting.Drill down into physicians’ treatment sequences and understand who to position against…
Glomerulonephritis – Current Treatment – Current Treatment: Physician Insights – Glomerulonephritis (US)
Glomerulonephritis (GN) is a condition involving inflammation of the glomerulus, which plays an important role in the filtration of blood into the kidney. If the glomerulus becomes inflamed and…
Hypertension – Current Treatment – Treatment Algorithms: Claims Data Analysis – Hypertension (US)
Hypertension is one of the most common medical conditions in the world, and in the United States, the Centers for Disease Control and Prevention estimates that 116 million people have it. A wide…
Chronic Myeloid Leukemia – Current Treatment – Current Treatment: Physician Insights – Chronic Myeloid Leukemia (US)
The chronic myeloid leukemia (CML) drug-treatment market is dominated by BCR-ABL tyrosine kinase inhibitors, notably imatinib (Novartis’s Gleevec; generics); these agents enable many CML patients…
Hepatitis B Virus – Geographic Focus: China – Hepatitis B Virus – China In-Depth – China
The prevalence of HBV is a major public health concern in China. Patients chronically infected with HBV are at high risk of developing hepatic cirrhosis and hepatocellular carcinoma. The majority…
Multiple Sclerosis – Geographic Focus: China – Multiple Sclerosis: China In-Depth (China)
Multiple sclerosis (MS), a chronic immune-mediated disease of the nervous system, is classified as a rare disease in China because of its low prevalence in that country. Traditionally, MS patients…
